These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 8752188

  • 21. Intravenous amiodarone vs propafenone for atrial fibrillation and flutter after cardiac operation.
    Di Biasi P, Scrofani R, Paje A, Cappiello E, Mangini A, Santoli C.
    Eur J Cardiothorac Surg; 1995; 9(10):587-91. PubMed ID: 8562105
    [Abstract] [Full Text] [Related]

  • 22. Propafenone for the treatment of supraventricular tachycardia and atrial fibrillation: a meta-analysis.
    Reimold SC, Maisel WH, Antman EM.
    Am J Cardiol; 1998 Oct 16; 82(8A):66N-71N. PubMed ID: 9809903
    [Abstract] [Full Text] [Related]

  • 23. Clinical comparison of ibutilide and propafenone for converting atrial flutter.
    Sun JL, Guo JH, Zhang N, Zhang HC, Zhang P.
    Cardiovasc Drugs Ther; 2005 Jan 16; 19(1):57-64. PubMed ID: 15883757
    [Abstract] [Full Text] [Related]

  • 24. Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter.
    Antman EM, Beamer AD, Cantillon C, McGowan N, Goldman L, Friedman PL.
    J Am Coll Cardiol; 1988 Oct 16; 12(4):1005-11. PubMed ID: 3417972
    [Abstract] [Full Text] [Related]

  • 25. Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm: a prospective parallel placebo-controlled multicentre study.
    Capucci A, Villani GQ, Aschieri D, Piepoli M.
    Int J Cardiol; 1999 Feb 28; 68(2):187-96. PubMed ID: 10189007
    [Abstract] [Full Text] [Related]

  • 26. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy.
    Pritchett EL, McCarthy EA, Wilkinson WE.
    Ann Intern Med; 1991 Apr 01; 114(7):539-44. PubMed ID: 2001087
    [Abstract] [Full Text] [Related]

  • 27. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study.
    Bianconi L, Mennuni M, Lukic V, Castro A, Chieffi M, Santini M.
    J Am Coll Cardiol; 1996 Sep 01; 28(3):700-6. PubMed ID: 8772759
    [Abstract] [Full Text] [Related]

  • 28. Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
    Manz M, Lüderitz B.
    Eur Heart J; 1993 Sep 01; 14 Suppl E():91-8. PubMed ID: 8223763
    [Abstract] [Full Text] [Related]

  • 29. Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs.
    Antman EM, Beamer AD, Cantillon C, McGowan N, Friedman PL.
    J Am Coll Cardiol; 1990 Mar 01; 15(3):698-707. PubMed ID: 2303641
    [Abstract] [Full Text] [Related]

  • 30. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ.
    Am J Cardiol; 1996 Jan 25; 77(3):83A-88A. PubMed ID: 8607396
    [Abstract] [Full Text] [Related]

  • 31. Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation.
    Bellandi F, Simonetti I, Leoncini M, Frascarelli F, Giovannini T, Maioli M, Dabizzi RP.
    Am J Cardiol; 2001 Sep 15; 88(6):640-5. PubMed ID: 11564387
    [Abstract] [Full Text] [Related]

  • 32. Oral propafenone therapy for patients with paroxysmal supraventricular tachyarrhythmia.
    Allen BJ, Brodsky MA, Doria R, Luckett CR, Thomas R, Henry WL.
    Chest; 1988 Oct 15; 94(4):853-4. PubMed ID: 3168580
    [No Abstract] [Full Text] [Related]

  • 33. Avoiding drug problems. The safety of drugs for supraventricular tachycardia.
    Reimold SC.
    Eur Heart J; 1997 May 15; 18 Suppl C():C40-4. PubMed ID: 9152674
    [Abstract] [Full Text] [Related]

  • 34. Drug therapy of supraventricular tachyarrhythmias--based on efficacy or futility?
    Cobbe SM.
    Eur Heart J; 1994 Apr 15; 15 Suppl A():22-6. PubMed ID: 8070493
    [Abstract] [Full Text] [Related]

  • 35. Conversion of recent onset atrial fibrillation with single loading oral dose of propafenone: is in-hospital admission absolutely necessary?
    Botto GL, Bonini W, Broffoni T, Molteni S, Lombardi R, Alfieri G, Barone P, Bernasconi G, Ferrari G.
    Pacing Clin Electrophysiol; 1996 Nov 15; 19(11 Pt 2):1939-43. PubMed ID: 8945073
    [Abstract] [Full Text] [Related]

  • 36. Safety of long-term flecainide and propafenone in the management of patients with symptomatic paroxysmal atrial fibrillation: report from the Flecainide and Propafenone Italian Study Investigators.
    Chimienti M, Cullen MT, Casadei G.
    Am J Cardiol; 1996 Jan 25; 77(3):60A-75A. PubMed ID: 8607393
    [Abstract] [Full Text] [Related]

  • 37. [Outpatient treatment of recurrent atrial fibrillation with the "pill-in-the-pocket" approach: practical aspects].
    Alboni P, Botto GL, Baldi N.
    Ital Heart J Suppl; 2005 Jun 25; 6(6):335-40. PubMed ID: 16013424
    [Abstract] [Full Text] [Related]

  • 38. Comparisons of oral propafenone and sotalol as an initial treatment in patients with symptomatic paroxysmal atrial fibrillation.
    Lee SH, Chen SA, Tai CT, Chiang CE, Wen ZC, Chen YJ, Yu WC, Huang JL, Fong AN, Cheng JJ, Chang MS.
    Am J Cardiol; 1997 Apr 01; 79(7):905-8. PubMed ID: 9104904
    [Abstract] [Full Text] [Related]

  • 39. Unstable wide complex tachycardia during propafenone therapy.
    Tsai CF, Sia SK, Lin MC, Wu DJ, Ueng KC.
    Resuscitation; 2010 Aug 01; 81(8):1046-7. PubMed ID: 20488610
    [No Abstract] [Full Text] [Related]

  • 40. [The efficacy of propafenon in the case of supraventricular atrioventricular tachycardia].
    Chachua T, Abuladze G, Nebieridze M.
    Georgian Med News; 2010 Jun 01; (183):18-21. PubMed ID: 20622270
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.